Rabbit Polyclonal BAAT antibody. Suitable for WB, IHC-P and reacts with Human samples. Immunogen corresponding to Recombinant Fragment Protein within Human Bile acid-CoA:amino acid N-acyltransferase.
pH: 7
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 20% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
WB | IHC-P | |
---|---|---|
Human | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/500.00000 - 1/3000.00000 | Notes Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/100.00000 - 1/1000.00000 | Notes - |
Catalyzes the amidation of bile acids (BAs) with the amino acids taurine and glycine (PubMed:12239217, PubMed:12810727, PubMed:2037576, PubMed:8034703). More than 95% of the BAs are N-acyl amidates with glycine and taurine (PubMed:8034703). Amidation of BAs in the liver with glycine or taurine prior to their excretion into bile is an important biochemical event in bile acid metabolism (PubMed:12810727). This conjugation (or amidation) plays several important biological roles in that it promotes the secretion of BAs and cholesterol into bile and increases the detergent properties of BAs in the intestine, which facilitates lipid and vitamin absorption (PubMed:12810727). May also act as an acyl-CoA thioesterase that regulates intracellular levels of free fatty acids (PubMed:12239217, PubMed:12810727, PubMed:8034703). In vitro, catalyzes the hydrolysis of long- and very long-chain saturated acyl-CoAs to the free fatty acid and coenzyme A (CoASH), and conjugates glycine to these acyl-CoAs (PubMed:12810727).
Bile acid-CoA:amino acid N-acyltransferase, BACAT, BAT, Bile acid-CoA thioesterase, Choloyl-CoA hydrolase, Glycine N-choloyltransferase, Long-chain fatty-acyl-CoA hydrolase, BAAT
Rabbit Polyclonal BAAT antibody. Suitable for WB, IHC-P and reacts with Human samples. Immunogen corresponding to Recombinant Fragment Protein within Human Bile acid-CoA:amino acid N-acyltransferase.
pH: 7
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 20% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
BAAT also known as Bile Acid-CoA: Amino Acid N-Acyltransferase is an enzyme that catalyzes the transfer of amino acids to bile acids forming conjugated bile acids. This process increases bile acid solubility and facilitates its function. BAAT has a molecular mass of approximately 47 kDa and is highly expressed in the liver. This expression is central for the enzyme's role in facilitating bile acid processing which is critical in fat digestion and absorption.
BAAT plays an important role in conjugating bile acids with amino acids such as glycine and taurine. This conjugation modifies the hydrophobicity and toxicity of bile acids making them more water-soluble. BAAT operates within the mitochondria and functions as an independent enzyme rather than being part of a larger enzymatic complex. Its essential role lies in maintaining the homeostasis of bile acids which is important for lipid metabolism.
BAAT is a part of the bile acid biosynthesis pathway. It assists in the conversion process that ensures the enterohepatic circulation of bile acids. Within this pathway BAAT works closely with enzymes like the cytochrome P450 family especially CYP7A1 which initiate bile acid synthesis. This partnership maintains the cycle of conversion and reabsorption of bile acids ensuring their availability for dietary fat processing.
BAAT relates significantly to disorders affecting bile acid metabolism such as cholestasis and gallstones. Abnormalities or deficiencies in BAAT activity can disrupt bile acid homeostasis contributing to these conditions. Moreover BAAT dysfunction is closely associated with defects in CYP7A1 as both enzymes play interconnected roles in bile acid synthesis and regulation. Understanding these interactions can provide insights into therapeutic approaches for bile-related disorders.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
10% SDS PAGE
All lanes: Western blot - Anti-BAAT antibody (ab154918) at 1/1000 dilution
Lane 1: A431 (Human epidermoid carcinoma cell line) whole cell lysate at 30 µg
Lane 2: HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 30 µg
Predicted band size: 46 kDa
Paraffin-embedded human hepatoma tissue stained for BAAT using ab154918 at 1/500 dilution in immunohistochemical analysis. Antigen retrieval step: EDTA based pH 8.0 buffer, 15 mins.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com